chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Additional Details: Patient informed pharmacist of vasovagal history of passing out from vaccines. Patient passed out 3 minutes after administration and was layed to floor by pharmacist and her close friend. Patient possibly started to a 15 second tonic-clonic seizure from the vaccine. Previous history of seizures.
Large raised red thick oblong 2 1/2 - 3" area on injection site noted after injection. Took BENADRYL. Next morning, redness slightly reduced, but now area is twice the size, very uncomfortable. Area continues to grow up to 6 plus inches, underarm very sore, made appointment w/clinic. Diagnosed w/skin infection (6/12/17) and prescribed strong antibiotic - AMOX-CLAV 875 mg tab (14) 2 per day. Little to no improvement.
Pfizer Covid vaccine received on 9/9/21. Patient got a rash and hives starting on 9/14/21.
child appeared with facial flushing and a fine rash on her face, hands, back and abdomen.
Fever 103 R next morning; congestion (nasal) 2 days later; Screaming relentlessly for 3-4 hrs @ a time p/shot; off & on for 2 days;
Arthralgia, arthritis, joint pain in arms, knees, ankles. Difficulty walking. Continual duration of symptoms with progressive deterioration over time.
Patient tested positive for COVID and completed the Pfizer vaccine series > 14 days prior to this
Light colored rash down left side of neck and onto left shoulder area. Only lasted a few hours. No meds or treatment needed.
cramps; tingling on head, face, arms and legs; Initial information received on 14-Nov-2019 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves a female patient who experienced cramps (muscle spasms) and tingling on head, face, arms and legs (Paraesthesia), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date of Sep-2018, the patient developed a serious cramps (muscle spasms) and tingling on head, face, arms and legs (paraesthesia) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient was hospitalized one weeks after receiving the vaccine.  Other relevant tests were not reported.  Final diagnosis was tingling on head, face, arms and legs and cramps.  Patient has been treated by a neurologist.  The patient outcome is reported as Unknown for both the events.  Information on the batch number was requested.; Sender's Comments: This case concerns a female patient who presented with muscle cramps and tingling on head, face, arms and legs after vaccination with FLUZONE QUADRIVALENT. The time to onset is unknown. However, patient's medical condition at time of vaccination and lab test ruling out alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
The patient was vaccinated and said that she feels dizzy, nervous. The patient sat on the chair ,passed out and had a seizure.
Baby screamed for more than 24 hours, stopped sleeping, stopping breastfeeding on both sides and only made it through one side before starting to throw up, stopped pooping immediately after shot and had normally pooped 5-6 times a day, didn't poop again for 4 days and had to have a suppository to do it, rash on forehead, staring off into space, seizure like behaviors with body convulsing/foam at mouth, stopped breathing and turned purple, stopped making eye contact. After not pooping again, admitted to ICU after ER visit. Second round of not pooping again went on for 7 days and suppository came out whole twice. Went to a new pediatrician who put baby on cleansing system and special vitamins to get her system back up and running. Her nervous system and digestive system had shut down.
Diluted with sterile water instead of sodium chloride. Administered via IM around 5:20PM on 09/30/2021.
After client completed 15 minute waiting period, she reported feeling "fuzzy" upon standing. Further described as lightheadedness. Also reported HA that started at nape of neck and extended to forehead. HA described at "dull." Pain 2-3 on 0-10 pain scale. VS assessed. 140/90. Pulse 76. Continued assessment. By 1040 reports pain 3-4/10, but pain only located at left side of forehead. Reports feels much better, besides the HA. Felt well enough to leave. Escorted to car--daughter present and driver.
I am a practicing physician. I had my two doses of Covid Vaccine- (second dose was on June24th) and had no severe adverse reactions what so ever, except for the common pain at injection site and some myalgia. I moved in August and as per the School?s mandate to get vaccinated with an FDA approved Vaccine,  I went for my first Jab of Pfizer at Pharmacy, where I was paying a visit to my sister?s family. I got my first shot on 24th of August at around 1:20 pm. I had a regular day with no immediate/anaphylactic reactions. But by the morning next day ie.25th of August, I had severe itching all over my body. I developed red blotchy hives which were severely itchy. Being a Doctor I just applied some topical Calamine and some cold sponges. I kept on doing this for two days after which I started taking Antihistamines (cetirizine and fexofenadine) based on symptoms and it gave me some relief and I started believing that this would subside. After a week of antihistamines, by 2nd of September the urticaria did subside a bit. But after two days, the welts started again with full force (4th of September) and I started taking medicine regularly. My urticaria has never really subsided completely, on top of it I noticed dermatographia as well. I am now using Cetrizine regularly. I had a belief that like every other adverse reactions of covid vaccine, this condition would as well get better by 2-3 weeks. Its been more than 3 weeks now and the calamine no longer works and I had to resort to use topical steroids (Desonide 5%) in extreme conditions, when the itching is very severe.  Inspite of regular medicine, I keep  getting these flareup every other day. I am really very concerned, now that my second dose is due in few days and I am afraid how to go about this situation. Please guide me in this regard.
Has a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Has a lot of pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Has a lot of pain). At the time of the report, PAIN (Has a lot of pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Received a flu shot at mid morning, around 2:30pm c/o chest tightness. Use Albuterol inhaler 2x with no relief. Went home, used nebulizer 3x (between 3pm - 12am) with little relief. Stayed home the next day, use of nebulizer - also with dry cough. Felt better & returned to work on the 3rd day.
Tachycardia; Allergic reaction; Dizziness; High BP; This spontaneous case was reported by a health care professional and describes the occurrence of TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypersensitivity reaction (Past allergies).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP). On 29-Dec-2020, TACHYCARDIA (Tachycardia), DIZZINESS (Dizziness) and HYPERTENSION (High BP) had resolved. At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Blood pressure measurement: 174/110 mmhg (High) High. On 29-Dec-2020, Body temperature: 36.6 (normal) Normal. On 29-Dec-2020, Heart rate: 137 (High) High pulse rate. On 29-Dec-2020, Respiratory rate: 20 bpm (normal) Normal. On 08-Jan-2021, Blood pressure measurement: 155/82 mmhg (High) High. On 08-Jan-2021, Body temperature: 37.6 (normal) Normal. On 08-Jan-2021, Heart rate: 123 (High) High. On 08-Jan-2021, Respiratory rate: 19 bpm (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  Treatment included: Blood pressure medications and oxygen  It was also stated that Tachycardia was the residual effect of the events   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 contains: Updated reporter information; Updated patient details; Updated Lab data; Updated Event- Difficulty breathing; Updated Stop dates of events;
Left side (neck) enlarged lymph nodes; Swollen neck; Numb under chin; Dose received 3; This is a spontaneous report from a contactable reporter (other healthcare professional). The reporter is the patient.  A 58-year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Nov2021 (Lot number: unknown) at the age of 58 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Gastroparesis" (unspecified if ongoing) and "Blood pressure high" (unspecified if ongoing), notes: High blood pressure. Concomitant medications included: TOPROL; LAMICTAL; PROZACTIN; BETHANECOL; NEXIUM and PEP C. Past drug history included: Morphine, reaction: "Drug allergy" and Reglan, reaction: "Drug allergy". Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Anatomical location: Left arm, Route of administration: Unspecified), administration date: 05Apr2021, when the patient was 57 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: UNKNOWN, Anatomical location: Left arm, Route of administration: Unspecified), administration date: 04May2021, when the patient was 57 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 27Nov2021, outcome "unknown", described as "Dose received 3"; LYMPHADENOPATHY (non-serious) with onset 03Dec2021, outcome "not recovered", described as "Left side (neck) enlarged lymph nodes"; SWELLING (non-serious) with onset 03Dec2021, outcome "not recovered", described as "swollen neck"; HYPOAESTHESIA (non-serious) with onset 03Dec2021, outcome "not recovered", described as "numb under chin". The events "Left side (neck) enlarged lymph nodes", "swollen neck" and "numb under chin" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, swelling and hypoaesthesia.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to COVID vaccine. It was reported that the reaction is 1 week after injection of booster. Since the vaccination, the patient had been tested for COVID-19. The patient underwent the following laboratory tests and procedures which included: SARS-CoV-2 test by test type nasal swab on an unknown date and the result was UNKNOWN RESULT.  The lot number for BNT162b2 was not provided and will be requested during follow up.
pt died at home after being in the hospital from 9/27 - 10/8/21 with COVID pneumonia; pt took monoclonal antibodies but started having and increase in SOB; poor appetite, V/D, fevers; started on Decadron and Remdesivir; pt was dc'd to home hospice where he died the next day
breastfeeding; breastfeeding; Soreness towards her arm and shoulder; I couldn't move my arm; It was from the shoulder all the way down to the wrist; I got little nervous; I panicked; Soreness towards her arm and shoulder; I couldn't move my arm; It was from the shoulder all the way down to the wrist; I got little nervous; I panicked; This is a spontaneous report from a Pfizer-sponsored program Support and from a contactable 38-Year-Old female consumer (Patient). A 38-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0181), via an unspecified route on 30Jul2021 (at the age of 38-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced Soreness towards her arm and shoulder and couldn't move her arm. It was from the shoulder all the way down to the wrist and patient got little nervous and panicked. After she received her first dose, she was breastfeeding and the mother experienced after the first dose some soreness towards her arm and shoulder and she said that her baby also had a reaction from the breastfeeding and had some projectile vomiting. Consumer stated, "So on the first shot that I got, my baby, he just, he did not take nothing all day, he was vomiting all day and I had my arm was you know, I couldn't move my arm for the first day. It was from the shoulder all the way down to the wrist. The second shot it was just like just at the injection site, like a normal shot (further clarification unknown), nothing out of ordinary and then it is fine with the 'second shot'." Patient did not receive treatment for the events. The outcome of the events was unknown.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101192776 EDP (baby 's 2nd dose);US-PFIZER INC-202101192586 EDP (baby 's 1st dose)
Blood Clots noted all over lungs; Abdominal pain radiating from right side to left side then to collar bone; Abdominal pain-right side; This spontaneous case was reported by a patient and describes the occurrence of PULMONARY EMBOLISM (Blood Clots noted all over lungs) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037421B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gallbladder pain.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced ABDOMINAL PAIN (Abdominal pain-right side). On 30-Apr-2021, the patient experienced PAIN (Abdominal pain radiating from right side to left side then to collar bone). On 04-May-2021, the patient experienced PULMONARY EMBOLISM (Blood Clots noted all over lungs) (seriousness criteria hospitalization and medically significant). On 30-Mar-2021, ABDOMINAL PAIN (Abdominal pain-right side) had resolved. At the time of the report, PULMONARY EMBOLISM (Blood Clots noted all over lungs) and PAIN (Abdominal pain radiating from right side to left side then to collar bone) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, Computerised tomogram: Blood clot noted on lungs (all over).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was given IV and oral blood thinner medication as a treatment.  Company comment: Very limited information regarding this event has been provided at this time. It is not clear if abdominal pain was gallbladder pain and surgery was prior to onset of pulmonary embolism. Details of the events and discharge summary is required for further evaluation.; Sender's Comments: Very limited information regarding this event has been provided at this time. It is not clear if abdominal pain was gallbladder pain and surgery was prior to onset of pulmonary embolism. Details of the events and discharge summary is required for further evaluation.
chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). The patient was treated with IBUPROFEN for Chills and Fever, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Chills and Fever, at an unspecified dose and frequency. At the time of the report, CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient woke up to chills and fever after 10 days. Concomitant medications were not provided.
itching; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TIMOLOL, AMLODIPINE, CHLORTHALIDONE, ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PRURITUS (itching) and RASH (rash). At the time of the report, PRURITUS (itching) and RASH (rash) outcome was unknown.            The treatment involved Benadryl, topical rubbing alcohol and hydrocortisone cream, to relieve the symptoms.   This case was linked to MOD-2021-089112 (Patient Link).
Vaccinated with the first dose of RabAvert in March, missed the date for the second dose; Case reference number US-BN-2023-000810 is a spontaneous case report initially received on 08-May-2023 from a consumer via Communication (reference number: USBAV23-0621) and concerns a male patient of unknown age.  The patient's relevant medical history and concomitant medication details were not provided.  On an unspecified date in March of unspecified year, the patient was vaccinated with the first dose of RabAvert vaccine (batch number not provided), at unknown dose, at an unknown route or site of administration, for pre-exposure prophylaxis.  As reported, the patient missed the date for the second RabAvert dose (explicitly coded as 'incomplete course of vaccination').  At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert vaccine.  Additional information received on 09-May-2023 included local case ID.; Reporter's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert vaccine for pre-exposure prophylaxis and as reported, the patient missed the date for the second dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.; Sender's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert vaccine for pre-exposure prophylaxis and as reported, the patient missed the date for the second dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.
Pt started with reaction as needle for Hep A immunization was removed from her arm. Her eyes rolled back in her head, she got very pale, and her arms were making jerking movements. This lasted about 90 seconds.
Started feeling fatigue after the first few days post injection. Over the last week he started feeling dizziness, head pressure, and nausea that might be caused by visual impairment. He is seeing "floaters". He was seen by a doctor who also contacted an infectious disease doctor. They did CT scan, bloodwork, and routine eye exam and all were normal.
This case was reported by a pharmacist via call center representative and described the occurrence of diarrhea in a 65-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included cold sores. On 27th February 2019, the patient received the 1st dose of SHINGRIX. On 28th February 2019, 1 days after receiving SHINGRIX, the patient experienced diarrhea, gastrointestinal disorder and pain in arm. In March 2019, the patient experienced cold sores lip. The patient was treated with acyclovir. On an unknown date, the outcome of the diarrhea, gastrointestinal disorder, pain in arm and cold sores lip were unknown. It was unknown if the reporter considered the diarrhea, gastrointestinal disorder, pain in arm and cold sores lip to be related to SHINGRIX. Additional details were provided as follows: The patient experienced a sore arm and gastrointestinal (GI) issues, mostly diarrhea. A couple of days after that, the patient experienced cold sores on her upper and lower lips. The patient went to her physician and was treated with acyclovir. The patient had a history of cold sores but not this severe. The pharmacist did not had access to the batch number and expire date at the time of reporting as she was at home.
Extreme reactions to every shot; Was really sick; High fever; Had lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Extreme reactions to every shot), ILLNESS (Was really sick), PYREXIA (High fever) and LYMPHADENOPATHY (Had lymph nodes) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Extreme reactions to every shot), ILLNESS (Was really sick), PYREXIA (High fever) and LYMPHADENOPATHY (Had lymph nodes). At the time of the report, VACCINATION COMPLICATION (Extreme reactions to every shot), ILLNESS (Was really sick), PYREXIA (High fever) and LYMPHADENOPATHY (Had lymph nodes) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2022-543645 (Patient Link).   Reporter did not allow further contact